SWX:ROGPharmaceuticals
How Investors Are Reacting To Roche Holding (SWX:ROG) CE Mark For Elecsys NfL MS Blood Test
In early April 2026, Roche announced that its Elecsys Neurofilament Light Chain (NfL) blood test received CE mark approval for detecting neuroinflammation in adults with relapsing-remitting multiple sclerosis, enabling minimally invasive monitoring via its widely installed cobas instruments.
This approval could materially change multiple sclerosis care pathways by shifting more frequent disease monitoring from hospital-based MRI scans to accessible, standardized blood testing.
Next, we’ll...